HBM Financial Statements From 2010 to 2024

HBMN Stock  CHF 175.60  5.80  3.20%   
HBM Healthcare financial statements provide useful quarterly and yearly information to potential HBM Healthcare Investments investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on HBM Healthcare financial statements helps investors assess HBM Healthcare's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting HBM Healthcare's valuation are summarized below:
HBM Healthcare Investments does not right now have any fundamental trends for analysis.
Check HBM Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HBM Healthcare's main balance sheet or income statement drivers, such as , as well as many indicators such as . HBM financial statements analysis is a perfect complement when working with HBM Healthcare Valuation or Volatility modules.
  
This module can also supplement various HBM Healthcare Technical models . Check out the analysis of HBM Healthcare Correlation against competitors.

HBM Healthcare Investments Company Operating Margin Analysis

HBM Healthcare's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current HBM Healthcare Operating Margin

    
  1.00 %  
Most of HBM Healthcare's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, HBM Healthcare Investments is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, HBM Healthcare Investments has an Operating Margin of 1.003%. This is 102.86% lower than that of the Healthcare sector and 100.89% lower than that of the Biotechnology industry. The operating margin for all Switzerland stocks is 118.2% lower than that of the firm.

HBM Healthcare Inves Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining HBM Healthcare's current stock value. Our valuation model uses many indicators to compare HBM Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across HBM Healthcare competition to find correlations between indicators driving HBM Healthcare's intrinsic value. More Info.
HBM Healthcare Investments is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the HBM Healthcare's earnings, one of the primary drivers of an investment's value.

About HBM Healthcare Financial Statements

HBM Healthcare investors use historical fundamental indicators, such as HBM Healthcare's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in HBM Healthcare. Please read more on our technical analysis and fundamental analysis pages.
HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund exits its portfolio companies through trade sale or IPO. HBM Healthcare operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for HBM Stock Analysis

When running HBM Healthcare's price analysis, check to measure HBM Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HBM Healthcare is operating at the current time. Most of HBM Healthcare's value examination focuses on studying past and present price action to predict the probability of HBM Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HBM Healthcare's price. Additionally, you may evaluate how the addition of HBM Healthcare to your portfolios can decrease your overall portfolio volatility.